Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab

PURPOSE: The aim of this study is to report the short-term efficacy of aflibercept in the treatment of neovascular age-related macular degeneration (AMD) with associated retinal pigment epithelial detachment (PED) which is refractory or develops tachyphylaxis to bevacizumab and ranibizumab. METHODS:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Patel, K H, Chow, C C, Rathod, R, Mieler, W F, Lim, J I, Ulanski, L J, Leiderman, Y I, Arun, V, Chau, F Y
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Case Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650278/
https://ncbi.nlm.nih.gov/pubmed/23558214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2013.31
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars